PR97381

TAIPEI, Aug. 16, 2022 /PRNewswire=KYODO JBN/ --

ICP DAS - BMP (Biomedical Polymers), a Taiwanese medical TPU (thermoplastic

polyurethane) supplier, will exhibit at MEDICAL MANUFACTURING ASIA 2022, the

5th Manufacturing Processes for Medical Technology Exhibition and Conference,

which provides excellent business opportunities in medical technology in the

Southeast Asian market. The exhibition will take place at the Marina Bay Sands

Expo and Convention Centre in Singapore from August 31 until September 2, 2022.

ICP DAS - BMP will showcase three series of highly stable medical grade TPU

pellets, namely, Alithane™ (ALP series), Durathane™ (ALC series), and Arothane™

(ARP series). A new range of pellets with 30% (W30) tungsten content will be

presented at the exhibition as well. ICP DAS - BMP is pleased to announce the

launch of three new production lines, in addition to the two already operating.

The third production line will start operating in a couple of months. Also, by

the end of this year, the production of pellets with a tungsten content of 40%

(W40) and 50% (W50), respectively, will be launched.

All medical grade TPU pellets by ICP DAS - BMP are 100% produced in Taiwan and

have excellent mechanical properties, chemical resistance, and radiodensity;

they can also be color-matched. To provide customers with the best service, ICP

DAS - BMP offers better lead times and accepts smaller quantity orders. Medical

grade TPU pellets can be used for various applications, such as drug delivery,

wound care, cardiology, urology, orthodontics, and others.

As most countries began to consider replacing PVC (polyvinyl chloride) with

medical grade TPU, the use of medical grade TPU pellets has become a critical

part of the global healthcare and emergency medical systems. ICP DAS - BMP

proudly notes that the company has already achieved impressive success with

domestic and foreign medical device manufacturers, including those from Korea,

Israel, France, and others using medical grade TPU for injection molding

methods.

The ICP DAS - BMP team is looking forward to seeing visitors from August 31 to

September 2, 2022, at Hall F, Booth 2V13. Meet the company's experts to learn

more about the latest developments in medical grade TPU.

About ICP DAS - BMP

In response to growing demand in the polymer industry, in 2018, ICP DAS

established a new business unit for the development and production of medical

grade TPU – ICP DAS - BMP. The company has achieved ISO 13485 certification for

its raw material warehouses and production lines.

ICP DAS - BMP has its own laboratories for polymerization, physical properties

analysis, and cytotoxicity testing. All the TPUs supplied by ICP DAS - BMP are

USP Class VI certified and compliant with the ISO 10993 international standard.

Materials have passed skin sensitization and cytotoxicity tests according to

ISO 10993-5 and ISO 10993-10. All this allows ICP DAS - BMP to guarantee

biocompatibility for medical device manufacturers.

For more details, please visit our website: https://bmp.icpdas.com/

Source: ICP DAS Co., Ltd.

Image Attachments Links:

   Link: http://asianetnews.net/view-attachment?attach-id=427203

   Caption: image